EQT Agrees to Qiagen Acquisition Valued at Approximately US$10.78 Billion

Swedish private-equity firm EQT agreed on 21 October 2026 to acquire Qiagen at an offer price of €46.50 per share, valuing the equity transaction at approximately €9.6 billion, or US$10.78 billion. Including approximately US$1.1 billion in net debt, the total enterprise value is around US$12.1 billion; completion is expected in mid-2027. Corporate-finance advisers and investors can explore opportunities in transaction modelling, due diligence and capital planning. HPC can support financial analytics and decision-support systems; contact HPC for a quotation. The transaction remains an agreed acquisition rather than a completed takeover.